Raman Bahal
Associate Professor/Pharmaceutical Science
Storrs Mansfield
Are you Raman Bahal?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Research Type: Journal Article
microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
2023
Research Type: Journal Article
Next-generation poly-L-histidine formulations for miRNA mimic delivery
2023
Research Type: Journal Article
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
2023
Research Type: Journal Article
Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Research Type: Journal Article
New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
2022
Research Type: Journal Article
Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
2022
Research Type: Journal Article
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
2022
Research Type: Journal Article
Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA.
2022
Research Type: Journal Article
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.
2022
Research Type: Journal Article
Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines
2022
Research Type: Journal Article
The growth of siRNA-based therapeutics: Updated clinical studies
2021
Research Type: Journal Article
Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
2021
Research Type: Journal Article